Gainesville, FL – According to filings with the U.S. Securities and Exchange Commission, AavantiBio is raising $106,856,458.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Bo Cumbo played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AavantiBio

AavantiBio, Inc. is a growing biotechnology company committed to developing new gene therapies, and is a startup dedicated to gene therapy research in the rare disease space.

To learn more about AavantiBio, visit http://www.aavantibio.com/

Contact:
Bo Cumbo, President and Chief Executive Officer
352-448-6551
https://www.linkedin.com/in/bocumbo/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved